View in EDS

Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population.

Saved in:
Bibliographic Details
Title: Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population.
Authors: van Kleef LA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Michel M; Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany., Savas M; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Obesity Center CGG, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Pustjens J; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Theel W; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., van Rossum EFC; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Obesity Center CGG, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Paik JM; The Global NASH Council, Washington, District of Columbia.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia., Younossi ZM; The Global NASH Council, Washington, District of Columbia.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia., Janssen HLA; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada., Labenz C; Department of Gastroenterology and Hepatology, University Medical Center Mainz, Mainz, Germany., Schattenberg JM; Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany., Brouwer WP; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Source: Gastro hep advances [Gastro Hep Adv] 2026 Mar 03; Vol. 5 (5), pp. 100912. Date of Electronic Publication: 2026 Mar 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc on behalf of the AGA Institute Country of Publication: Netherlands NLM ID: 9918350485906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-5723 (Electronic) Linking ISSN: 27725723 NLM ISO Abbreviation: Gastro Hep Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41953380
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Kleef+LA%22">van Kleef LA</searchLink>; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Michel+M%22">Michel M</searchLink>; Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany.<br /><searchLink fieldCode="AU" term="%22Savas+M%22">Savas M</searchLink>; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Obesity Center CGG, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pustjens+J%22">Pustjens J</searchLink>; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Theel+W%22">Theel W</searchLink>; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Rossum+EFC%22">van Rossum EFC</searchLink>; Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Obesity Center CGG, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Paik+JM%22">Paik JM</searchLink>; The Global NASH Council, Washington, District of Columbia.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia.<br /><searchLink fieldCode="AU" term="%22Younossi+ZM%22">Younossi ZM</searchLink>; The Global NASH Council, Washington, District of Columbia.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia.<br /><searchLink fieldCode="AU" term="%22Janssen+HLA%22">Janssen HLA</searchLink>; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Labenz+C%22">Labenz C</searchLink>; Department of Gastroenterology and Hepatology, University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Schattenberg+JM%22">Schattenberg JM</searchLink>; Department of Internal Medicine II, Saarland University Medical Center, Homburg, Germany.; Medical Faculty, Saarland University, Saarbrücken, Germany.<br /><searchLink fieldCode="AU" term="%22Brouwer+WP%22">Brouwer WP</searchLink>; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918350485906676%22">Gastro hep advances</searchLink> [Gastro Hep Adv] 2026 Mar 03; Vol. 5 (5), pp. 100912. <i>Date of Electronic Publication: </i>2026 Mar 03 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc+on+behalf+of+the+AGA+Institute%22">Elsevier Inc on behalf of the AGA Institute </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9918350485906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2772-5723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227725723%22">27725723 </searchLink><i>NLM ISO Abbreviation: </i>Gastro Hep Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41953380
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.gastha.2026.100912
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100912
    Titles:
      – TitleFull: Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Kleef LA
      – PersonEntity:
          Name:
            NameFull: Michel M
      – PersonEntity:
          Name:
            NameFull: Savas M
      – PersonEntity:
          Name:
            NameFull: Pustjens J
      – PersonEntity:
          Name:
            NameFull: Theel W
      – PersonEntity:
          Name:
            NameFull: van Rossum EFC
      – PersonEntity:
          Name:
            NameFull: Paik JM
      – PersonEntity:
          Name:
            NameFull: Younossi ZM
      – PersonEntity:
          Name:
            NameFull: Janssen HLA
      – PersonEntity:
          Name:
            NameFull: Labenz C
      – PersonEntity:
          Name:
            NameFull: Schattenberg JM
      – PersonEntity:
          Name:
            NameFull: Brouwer WP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 03
              Text: 2026 Mar 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2772-5723
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Gastro hep advances
              Type: main
ResultId 1